Approaches to the early treatment of invasive fungal infection

Leukemia & Lymphoma
J I ItoH M Lazarus

Abstract

Invasive fungal infections account for significant morbidity and mortality in the seriously immunocompromised host, especially those suffering from hematologic malignancies and the recipients of hematopoietic cell transplant. One of the reasons for the continuing high mortality rates due to invasive fungal infection is the delay in administering appropriate therapy. As preemptive antifungal therapy is not feasible for lack of a predictive test, early empiric therapy is currently the only approach likely to result in improvement in survival. Here, we present our approach to both invasive candidiasis and invasive mold infection. Therapy should be initiated at the first signs and symptoms of disease, utilizing knowledge of local fungal epidemiology, the patient's recent antifungal agent exposure, and the diagnostic tests immediately available, to select an appropriate antifungal agent most likely to be effective against the suspected fungal species.

References

Nov 1, 1994·The Journal of Antimicrobial Chemotherapy·D LawD W Denning
Jan 1, 1995·Respiration; International Review of Thoracic Diseases·M von EiffJ van de Loo
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D CaillotH Guy
Jun 20, 1998·Clinical Microbiology Reviews·T C WhiteR A Bowden
Oct 14, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Wong-BeringerB J Guglielmo
Oct 31, 1998·Antimicrobial Agents and Chemotherapy·E K ManavathuP H Chandrasekar
Jan 9, 1999·Clinical Microbiology Reviews·D J SheehanC M Sibley
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R WingardUNKNOWN L Amph/ABLC Collaborative Study Group
Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Walter T HughesLowell S Young
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrLawrence Corey
Apr 12, 2002·Lancet·Dimitrios P Kontoyiannis, Russell E Lewis
Apr 20, 2002·Current Opinion in Infectious Diseases·E G Arathoon
May 23, 2002·Antimicrobial Agents and Chemotherapy·Theodore C WhiteDavid A Stevens
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Sofia PereaThomas F Patterson
Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brian A Potoski, Jack Brown
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·Eric DannaouiUNKNOWN Eurofung Network
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Javier Capilla LuqueDavid A Stevens
Jul 18, 2003·Clinical Therapeutics·Jane P BarrettUNKNOWN Amphotericin B Systematic Review Study Group
Sep 25, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael BoeckhJohn Zaia
Oct 16, 2004·Expert Review of Anti-infective Therapy·Ralph H Raasch
Apr 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Barbara D Alexander, John R Wingard
Sep 27, 2005·The Lancet Infectious Diseases·W W HopeD W Denning
Feb 9, 2006·The Journal of Antimicrobial Chemotherapy·Michel LaverdièreDavid S Perlin
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·J SmithD Andes
Apr 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P H Chandrasekar, J D Sobel
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kevin W GareyDavid T Bearden
Sep 21, 2006·Infectious Disease Clinics of North America·Dimitrios P Kontoyiannis, Russell E Lewis
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshJohn R Perfect
Jan 26, 2007·The New England Journal of Medicine·Oliver A CornelyDavid Angulo-Gonzalez
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andres PascualOscar Marchetti
Jan 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshUNKNOWN Infectious Diseases Society of America
May 14, 2008·Revista iberoamericana de micología·Ana Espinel-Ingroff
Jul 1, 2008·Internal Medicine Journal·K A ThurskyD R Shaw

❮ Previous
Next ❯

Citations

Feb 11, 2011·Current Infectious Disease Reports·Susanne PerkhoferCornelia Lass-Flörl
Jul 14, 2011·Clinical Epidemiology·Jane KriengkauykiatSanjeet S Dadwal
Mar 5, 2016·Journal of Clinical Microbiology·Hana ObručováTomáš Freiberger

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

© 2021 Meta ULC. All rights reserved